Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Epigenetics and Nuclear Signaling Chromatin Modifying Enzymes Methylation

Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free (ab251164)

Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free (ab251164)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR18508] to LSD2 / AOF1 - BSA and Azide free
  • Suitable for: Flow Cyt, WB, IP, ICC/IF
  • Knockout validated
  • Reacts with: Mouse, Rat, Human

You may also be interested in

Product image
Anti-KMT3A / HYPB / HIF-1 antibody (ab230434)
Product image
Anti-CLLD8/SETDB2 antibody (ab13712)
Product image
Human EHMT2 (G9A) knockout HeLa cell lysate (ab257080)
Product image
Recombinant Human EED protein (His tag) (ab268453)

Overview

  • Product name

    Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free
    See all LSD2 / AOF1 primary antibodies
  • Description

    Rabbit monoclonal [EPR18508] to LSD2 / AOF1 - BSA and Azide free
  • Host species

    Rabbit
  • Tested applications

    Suitable for: Flow Cyt, WB, IP, ICC/IFmore details
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: HeLa, HAP1 and HCT116 cell lysates.
  • General notes

    Ab251164 is the carrier-free version of ab193080. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    ab251164 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C. Do Not Freeze.
  • Storage buffer

    pH: 7.2
    Constituent: PBS
  • Carrier free

    Yes
  • Concentration information loading...
  • Clonality

    Monoclonal
  • Clone number

    EPR18508
  • Isotype

    IgG
  • Research areas

    • Epigenetics and Nuclear Signaling
    • Chromatin Modifying Enzymes
    • Methylation
    • Epigenetics and Nuclear Signaling
    • Chromatin Modifying Enzymes
    • Methylation
    • Lysine demethylation

Images

  • Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free (ab251164)
    Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free (ab251164)
    All lanes : Anti-LSD2 / AOF1 antibody [EPR18508] (ab193080) at 1/1000 dilution

    Lane 1 : Wild-type HeLa cell lysate
    Lane 2 : KDM1B knockout HeLa cell lysate
    Lane 3 : HAP1 cell lysate
    Lane 4 : HCT116 cell lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) at 1/10000 dilution

    Predicted band size: 92 kDa
    Observed band size: 95 kDa
    why is the actual band size different from the predicted?



    This data was developed using the same antibody clone in a different buffer formulation (ab193080).

    Lanes 1-4: Merged signal (red and green). Green - ab193080 observed at 95 kDa. Red - loading control ab8245 observed at 36 kDa. 

     ab193080 Anti-LSD2 / AOF1 antibody [EPR18508] was shown to specifically react with LSD2 / AOF1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265969 (knockout cell lysate ab258016) was used.  Wild-type and LSD2 / AOF1 knockout samples were subjected to SDS-PAGE.  ab193080 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2. 5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free (ab251164)
    Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free (ab251164)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free (ab251164)

  •  
  • Product image

    Anti-LSD2 / AOF1 antibody (ab254571)

    Applications: WB

Clear all

Recently viewed products

  •  
  • Recombinant Human ITLN2 protein (ab127836)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.